Ampio Pharmaceuticals Inc. (AMPE) can make a big difference with a little luck

Ampio Pharmaceuticals Inc. (AMEX: AMPE) stock fell -0.48% on Monday to $0.27 against a previous-day closing price of $0.27. With 0.15 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.19 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.2900 whereas the lowest price it dropped to was $0.2605. The 52-week range on AMPE shows that it touched its highest point at $9.70 and its lowest point at $0.20 during that stretch. Beta for the stock currently stands at 1.71.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMPE was down-trending over the past week, with a drop of -18.15%, but this was up by 14.00% over a month. Three-month performance dropped to -48.82% while six-month performance fell -89.73%. The stock lost -96.38% in the past year, while it has gained 19.32% so far this year.

Float and Shares Shorts:

At present, 15.07 million AMPE shares are outstanding with a float of 13.95 million shares on hand for trading. On Dec 29, 2022, short shares totaled 0.23 million, which was 1.51% higher than short shares on Nov 29, 2022. In addition to Mr. Michael A. Martino as the firm’s CEO & Director, Dr. David Bar-Or M.D. serves as its Founder & Chairman of Scientific Advisory Board.

Institutional Ownership:

Through their ownership of 13.03% of AMPE’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 11.99% of AMPE, in contrast to 0.57% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in AMPE with 4.37% of the stake, The Vanguard Group, Inc. holds 659,252 shares worth 659,252. A second-largest stockholder of AMPE, BlackRock Fund Advisors, holds 308,936 shares, controlling over 2.05% of the firm’s shares. Millennium Management LLC is the third largest shareholder in AMPE, holding 179,480 shares or 1.19% stake. With a 0.26% stake in AMPE, the Bridgeway Ultra Small Company Mar is the largest stakeholder. A total of 38,534 shares are owned by the mutual fund manager. The Vanguard Russell 2000 Growth Inde, which owns about 0.13% of AMPE stock, is the second-largest Mutual Fund holder. It holds 20,222 shares valued at 4550.0. Vanguard Institutional Total Stoc holds 0.07% of the stake in AMPE, owning 11,192 shares worth 2518.0.


An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Sep 29, 2022, AMPE reported revenue of $0.00 and operating income of -$4.99M. The EBITDA in the recently reported quarter was -$7.62M and diluted EPS was -$0.30.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMPE since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AMPE analysts setting a high price target of $30.00 and a low target of $30.00, the average target price over the next 12 months is $30.00. Based on these targets, AMPE could surge 11011.11% to reach the target high and rise by 11011.11% to reach the target low. Reaching the average price target will result in a growth of 11011.11% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. AMPE will report FY 2022 earnings on 03/27/2024. Analysts have provided yearly estimates in a range of -$1.20 being high and -$1.20 being low. For AMPE, this leads to a yearly average estimate of -$1.20. Based on analyst estimates, the high estimate for the next quarter is -$0.30 and the low estimate is -$0.30. The average estimate for the next quarter is thus -$0.30.

Summary of Insider Activity:

Insiders traded AMPE stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *